Mirae Asset Global Etfs Holdings Ltd. Novo Cure LTD Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Novo Cure LTD stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 74,992 shares of NVCR stock, worth $822,662. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,992
Previous 72,490
3.45%
Holding current value
$822,662
Previous $2.16 Million
38.15%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NVCR
# of Institutions
260Shares Held
79.3MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$133 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$123 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$98.1 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$60.6 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$57.2 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.15B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...